Health Professional Radio - Podcast

Dr. Justin Odegaard, VP of Clinical Development at Guardant Health discusses a new study published in "Nature Medicine" (Oct 2020) which finds that the Guardant360® liquid biopsy rapid blood test is not only concordant to tissue biopsy, but more than doubles clinical trial enrollment and achieves similar treatment response and survival rates in patients with advanced gastrointestinal cancer.